Skip to contentSkip to navigation

Specialist Advice — 7 minutes

Colorectal cancer: Screening or diagnosis?

October 22, 2024

Raymond Lepage, PhD, Doctor in Biochemistry
Raymond Lepage, PhD, Doctor in Biochemistry
Science popularizer

By the end of 2024, there will be almost 247,000 new cancer diagnoses and 88,000 deaths in Canada [1]. A cancer diagnosis must be confirmed by a pathologist, who examines suspicious tissue samples from a biopsy under a microscope. The process of diagnosing cancer often involves complex and sometimes risky medical procedures, such as a surgical biopsy and colonoscopy. Because of the risks and complexity of these so-called “invasive” procedures, they cannot be applied to everyone in the general population or those at low risk of developing cancer; they must be reserved for those at highest risk.

colorectal

As a result, health authorities in developed countries, such as Canada, have set up population screening programs in order to identify those most at risk. These programs are based on simple, inexpensive, easily accessible and, above all, risk-free techniques. Such techniques also need to be highly sensitive in order to detect as many cases of cancer as possible at an early stage, when effective treatment can save lives. It is important to note that these programs may produce false-positive results, but these will be eliminated during subsequent diagnostic examinations.

Cancer screening programs in Quebec

  • Breast cancer: screening mammogram
  • Cervical cancer: screening for high-risk HPV genotypes
  • Cancer colorectal: fecal occult blood testing

Colorectal cancer screening program

With more than 25,000 new cases and 9,500 deaths per year, colorectal cancer is the third most frequently diagnosed cancer in Canada. In Quebec, it is the second leading cause of cancer deaths in both men and women.

The screening test is based on the fact that large polyps, tumours (also called “adenomas”) and cancers discharge small amounts of blood into the intestine, which are then passed in the stool. These quantities are generally too small to be detected by the naked eye, hence the term “occult blood.” In Quebec, the recommended screening test is the fecal immunochemical test (FIT), also known as the immunochemical fecal occult blood test (iFOBT) [2].

In theory, the larger and more advanced a polyp, tumour or cancer, the greater the amount of blood in the stool. However, this is not always the case: the discharge of blood may be irregular, and even a good-sized tumour may not have bled sufficiently by the time stool samples are collected for the screening test to be positive.

Who is eligible for screening?
  1. Anyone with a prescription issued by a health care professional is eligible.
  2. The test is also available without a prescription for people aged 50 to 74 without symptoms or particular risk factors, and from the age of 40 for those with a particular profile [2]. To determine your eligibility, please complete this short questionnaire.

Symptoms suggestive of colorectal cancer

  • Recent and persistent changes in bowel habits, such as diarrhea, constipation or pain during bowel movements
  • Visible blood in the stool, whether black or bright red
  • Bleeding after bowel movements
  • Documented, unexplained anemia

Special risks that justify going directly to a colonoscopy

  • Personal or family history of colorectal cancer, polyps or chronic inflammatory bowel disease, such as Crohn’s disease or ulcerative colitis.
  • Family history of genetic diseases that increase the risk of colorectal cancer, such as Lynch syndrome or the various forms of familial adenomatous polyposis (FAP).

Restrictions on access to the Quebec program without a doctor’s prescription

  • People over the age of 75
  • People who have had a FIT in the last two years
  • People who have had a virtual colonoscopy in the last five years
  • People who have had an optical colonoscopy in the last ten years
What does your FIT reveal?

Negative result: There is most likely no significant cancer, adenoma or polyps. A colonoscopy is not recommended. However, tumours do not bleed continuously, and a negative test does not entirely eliminate the possibility that a tumour or cancer is present. This is why the test should be repeated every two years.

Positive result: The fecal occult blood test is not a diagnostic test;: there may be blood in the stool for other reasons. A positive FIT result does not necessarily mean the presence of cancer, but it does indicate the need for a medical follow-up. Hemorrhoids, anal fissures, constipation or inflammatory bowel disease can also cause blood in the stool. In Quebec, out of every 1,000 people who take the screening test, between 30 and 40 will have blood in their stools. About half will show adenomas or large polyps during a colonoscopy, while about one in ten will have a developing cancer [3].

What is a colonoscopy?

A colonoscopy is an examination that involves inserting a long tube called an endoscope into the rectum. The endoscope is fitted with a small camera and a tool for removing small fragments of tissue. The tube is advanced slowly into the colon, ideally to the junction between the large and small intestines, known as the cecum.

The small camera transmits real-time images of the intestinal wall to a video screen, allowing the specialist performing the examination (the colonoscopist) to detect the presence of suspicious tissue, such as polyps or adenomas. Thanks to the integrated tool, biopsies can be performed or polyps completely removed (polypectomy). An optical colonoscopy requires adequate preparation of the colon: it must be completely emptied, and the patient is sedated during the procedure.

Colonoscopy results

A successful colonoscopy relies on good bowel preparation and complete visualization of the large intestine, right down to the cecum. A negative result means there is no evidence of cancer, and, therefore, no need to re-test for ten years. The patient is encouraged to repeat the FIT every two years [4]. A positive result, on the other hand, indicates the presence of cancer or “advanced” or “non-advanced” polyps. Depending on the number, appearance and size of the polyps, it will be necessary to either continue fecal immunochemical testing every two years (for small polyps) or schedule a new colonoscopy three to ten years later.

Early detection is a valuable ally for your health

As with many other cancers, survival is very high when colorectal cancer is diagnosed at an early stage. If this cancer is diagnosed at stage 1 (i.e. when the abnormal cells are still in their tissue of origin), the survival rate is over 90% five years after the diagnosis. Simply testing for blood in the stool with a FIT, therefore, has the potential to save many lives. With the test now available without a doctor’s prescription, it is recommended that all those concerned take full advantage of it [5].

For professional support, we're here for you.

Are you concerned about colorectal cancer? Complete our short questionnaire to confirm your eligibility for the screening program and order your at-home collection kit.

Order a screening kit

Do you already have a medical prescription for this test? Schedule an appointment online or contact Biron Health Group’s customer service at 1-833-590-2712.

Sources5
  1. Statistiques Canada. Cancer-statistiques spécifiques 2024. https://cdn.cancer.ca/-/media/files/research/cancer-statistics/2024-statistics/2024-cmaj/2024_cancer-specific-stats_fr.pdf? Consulté le 20 octobre 2024.
  2. Québec. Dépistage du cancer colorectal (côlon et rectum). https://www.quebec.ca/sante/problemes-de-sante/cancer/cancer-colorectal-colon-et-rectum/depistage-cancer-colorectal-colon-et-rectum. Consulté le 21 octobre 2024.
  3. INSPQ. Indicateurs pour l’Évaluation du programme québécois de dépistage du cancer colorectal. https://www.inspq.qc.ca/sites/default/files/publications/1712_indevalprogqcdepcancercolorec.pdf. Consulté le 21 octobre 2024.
  4. MSSS. Clientèle à risque de cancer colorectal. https://publications.msss.gouv.qc.ca/msss/fichiers/2022/22-902-15W.pdf. Consulté le 22 octobre 2024.
  5. Biron. Dépistage du cancer colorectal – Test RSOSi. https://www.biron.com/fr/laboratoire/depistage-cancer-colorectal/ Consulté le 22 octobre 2024.